Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01062347
Other study ID # 2006-004
Secondary ID
Status Completed
Phase Phase 1
First received February 3, 2010
Last updated June 6, 2017
Start date July 1, 2007
Est. completion date December 31, 2010

Study information

Verified date February 2010
Source International Centre for Diarrhoeal Disease Research, Bangladesh
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Zinc deficiency is a widespread public health problem in developing countries. The true prevalence of this condition remains uncertain because of lack of a specific, sensitive and reliable biomarker for assessment of human zinc status. The most widely used indicator for measuring zinc status is serum zinc level, which, however, is homeostatically regulated and influenced by stress and infection. To explore the possibility of using mRNA levels of zinc responsive genes as an indicator of zinc status, Cao and Cousins suggested metallothionein (MT) mRNA level in monocytes and peripheral blood mononuclear cells as an indicator of recent zinc uptake. However, the usefulness of MT mRNA is also limited because its level is influenced by other metals, such as copper, cadmium and cobalt and it is also affected by stress. Several authors have proposed that expression of zinc transporter genes might be useful markers of Zn status. Evidence shows reduction in dietary zinc content produces a marked increase in intestinal absorption and decrease in intestinal zinc losses. As zinc homeostasis is regulated in the intestine, study of the zinc transporters in this organ may provide indication of recent zinc uptake. Recently, a few studies have begun to investigate the applicability of using white blood cell zinc transporter expression as an indicator of zinc status and found that some of the transporters are zinc responsive. The primary objective of this study is to explore whether the expression of zinc responsive genes, such as zinc transporters in human intestinal mucosal cells, can be used as indicators of zinc status. The specific aims are to compare gene expression in: a) intestinal mucosal cells obtained by duodenal biopsy, b) sloughed intestinal mucosal cells isolated from feces, and c) peripheral blood mononuclear cells (PBMC) in fasting individuals who are receiving their usual diet + placebo or their usual diet + supplemental zinc (20 mg/d for 7 days). Gene expression values from intestinal mucosal cells (biopsy) will be compared between the placebo and zinc supplemented groups. Similar comparison will be done in the cells isolated from stool and PBMCs. This study will also provide an opportunity to compare the relative responsiveness of gene expression and serum zinc concentration following supplementation and to explore the kinetics of any changes in serum zinc concentration. Thus, blood samples will be obtained for measuring serum zinc concentration on two occasions prior to the interventions and at specified intervals during and after the intervention.


Recruitment information / eligibility

Status Completed
Enrollment 0
Est. completion date December 31, 2010
Est. primary completion date December 31, 2010
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 35 Years
Eligibility Inclusion Criteria:

- Healthy, non-smoking

Exclusion Criteria:

- Suffering from diarrhea

Study Design


Related Conditions & MeSH terms


Intervention

Biological:
Zinc


Locations

Country Name City State
Bangladesh Mirpur Dhaka

Sponsors (2)

Lead Sponsor Collaborator
International Centre for Diarrhoeal Disease Research, Bangladesh University of California, Davis

Country where clinical trial is conducted

Bangladesh, 

See also
  Status Clinical Trial Phase
Not yet recruiting NCT03353662 - Sub Regional Micronutrient Survey in Ethiopia
Completed NCT02126293 - Correction of Zinc Deficiency in Children With Chronic Kidney Disease and Kidney Transplant Phase 3
Terminated NCT01472211 - Water-based Zinc Intervention Trial in Zinc Deficient Children Phase 0
Completed NCT01061307 - An Efficacy Trial of Iron, Zinc and Vitamin A Fortified Rice in Children in Satun, Thailand Phase 0
Recruiting NCT03421314 - Effect of Zinc and Selenium Supplementation on HIV+ Individuals on Antiretroviral Treatment. N/A
Completed NCT02292303 - Clinical Trial to Determine the Bioavailability of Three Different Zinc Preparations N/A
Completed NCT02241330 - Efficacy of Zn Biofortified Wheat in Improving Zn Status in Indian School Children With Low Zn Status N/A
Completed NCT01221129 - Zinc and the Synthesis of Zinc Binding Proteins (Protocol B) N/A
Completed NCT04632771 - Nutritional Status and Bouillon Use in Northern Ghana
Recruiting NCT05236374 - Effects of Daily Beef Intake, as a Component of a Heart-Healthy Diet on Cellular Zinc N/A
Completed NCT02758444 - Effects of EED on Zn Absorption and Retention in Children From a MNP N/A
Completed NCT02760095 - Effects of EED on Zn Absorption and Retention in Children From a Standard Dose
Completed NCT02233764 - Effect of Iron/Zinc-Biofortified Pearl Millet on Growth and Immunity in Children Aged 12-18 Months in India N/A
Recruiting NCT05527899 - Zinc Intervention in Elderly for Prevention of Pneumonia Phase 2/Phase 3
Terminated NCT04983667 - Zinc-AA Supplementation During Pregnancy & Lactation to Assess Effects on ASD Prevalence in Offspring N/A
Completed NCT03293641 - Zinc Supplementation in Children With Sickle Cell Disease in Western Kenya N/A
Completed NCT05778383 - Zinc Supplementation Impact in Acute COVID-19 Clinical Outcomes Phase 4
Completed NCT04559152 - Zinc Supplementation During Pregnancy: Analysis of Maternal Serum Zinc, Cord Blood Osteocalcin and Neonatal Birth Length N/A
Recruiting NCT05085834 - Zinc Effect on Inflammation and Cardiovascular Risk in HIV Early Phase 1
Completed NCT02321865 - Dose Adjustment Study of NPC-02 in Patients With Zinc Deficiency Phase 3